A novel cholesteryl ester transfer protein promoter polymorphism (-971G/A) associated with plasma high-density lipoprotein cholesterol levels: Interaction with the TaqIB and - 629C/A polymorphisms

Atherosclerosis

Volumn 161, Issue 2, 2002, Pages 269-279

  Le Goff, Wilfried ^a   Guerin, Maryse ^a   Nicaud, Viviane ^b   Dachet, Christiane ^a   Luc, Gérald ^c   Arveiler, Dominique ^d   Ruidavets, J B ^e   Evans, Alun ^f   Kee, Frank ^f   Morrison, Caroline ^g   John Chapman, M ^a   Thillet, Joëlle ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSERM   (France)

^c MONICA Project   (France)

^d MONICA Project   (France)

^e MONICA Project   (France)

^f MONICA Project   (Ireland)

^g MONICA Project   (United Kingdom)

Author keywords

Cholesteryl ester transfer protein; High density lipoprotein cholesterol; Myocardial infarction; Polymorphism

Indexed keywords

ALANINE; CHOLESTEROL ESTER TRANSFER PROTEIN; DNA; GLYCINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA POLYMORPHISM; DNA TRANSCRIPTION; FEMALE; GENE FREQUENCY; GENETIC LINKAGE; GENETIC TRANSFECTION; HEART INFARCTION; HUMAN; HUMAN CELL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; RESTRICTION SITE;

ADULT; AGED; BASE SEQUENCE; CARDIOVASCULAR DISEASES; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; FEMALE; GENE EXPRESSION REGULATION; GENOTYPE; GLYCOPROTEINS; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROBABILITY; PROMOTER REGIONS (GENETICS); REGISTRIES; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; SITE-SPECIFIC DNA-METHYLTRANSFERASE (ADENINE-SPECIFIC);

EID: 18344364813     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00641-4     Document Type: Article

References (40)

1. Protein lipid relationship in human plasma. II. In atherosclerosis and related conditions
2. Reverse cholesterol transport
3. Plasma cholesteryl ester transfer protein
4. Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins
5. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation
6. Atherosclerotic disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase
7. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels
8. An interaction between the human cholesteryl ester transfer protein (CETP) and apolipoprotein A-I genes in transgenic mice results in a profound CETP-mediated depression of high density lipoprotein cholesterol levels
9. Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice
10. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein
11. Cloning and sequencing of human cholesteryl ester transfer protein cDNA
12. Organization of the human cholesteryl ester transfer protein gene
13. New functional promoter polymorphism, CETP/ - 629, in cholesteryl ester transfer protein (CETP) gene related to CETP mass and high density lipoprotein cholesterol levels: Role of Sp1/Sp3 in transcriptional regulation
14. Linkage of the cholesteryl ester transfer protein (CETP) gene to LDL particle size: Use of a novel tetranucleotide repeat within the CETP promoter
15. Identification of mutations in the cholesterol ester transfer protein in Europeans with elevated high density lipoprotein cholesterol
16. An StuI RFLP at the human cholesteryl ester transfer protein (CETP) locus
17. Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction
18. EcoN I polymorphism in the human cholesteryl ester transfer protein (CEPT) gene
19. Heterogeneity at the CETP gene locus. Influence on plasma CETP concentrations and HDL cholesterol levels
20. Extensive association analysis between the CETP gene and coronary heart disease phenotypes reveals several putative functional polymorphisms and gene-environment interaction
21. Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels
22. Allelic variation in the gene encoding the cholesteryl ester transfer protein is associated with variation in the plasma concentrations of cholesteryl ester transfer protein
23. Association between plasma HDL-cholesterol concentration and Taq1B CETP gene polymorphism in non-insulin-dependent diabetes mellitus
24. DNA polymorphism at the locus for human cholesteryl ester transfer protein (CETP) is associated with high density lipoprotein cholesterol and apolipoprotein levels
25. Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors. Associations between the TaqIB RFLP in the CETP gene and smoking and obesity
26. Polymorphisms of the gene coding for the cholesteryl ester transfer protein and plasma lipid levels in Italian and Greek migrants to Australia
27. Sex difference in the regulation of plasma high density lipoprotein cholesterol by genetic and environmental factors
28. Association of TaqIB polymorphism in the cholesteryl ester transfer protein gene with plasma lipid levels in a healthy Spanish population
29. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: The Framingham study
30. Relation of polymorphisms in the cholesteryl ester transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkers
31. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis
32. A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM study
33. Polymorphisms in the 5′ regulatory region of the tissue factor gene and the risk of myocardial infarction and venous thromboembolism: The ECTIM and PATHROS studies. Etude Cas-Temoins de l'Infarctus du Myocarde. Paris thrombosis case-control study
34. Two-site enzyme immunoassay of cholesteryl ester transfer protein with monoclonal and oligoclonal antibodies
35. DNA sequencing with chain-terminating inhibitors
36. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
37. Testing for association between disease and linked marker loci: A log-linear-model analysis
38. Transcriptional regulation of the cholesteryl ester transfer protein gene by the orphan nuclear hormone receptor apolipoprotein AI regulatory protein-1
39. Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene
40. Plasma concentrations of cholesteryl ester transfer protein in hyperlipoproteinemia. Relation to cholesteryl ester transfer protein activity and other lipoprotein variables